The combination of ATRA, 13-cRA, and 4-HPR with EGCG was investigated on SH-SY5Y cells, which is a neuroblastoma cell line lacking N-MYC amplification and overexpression, resulting in cell growth inhibition, apoptosis and N-MYC protein decrease [16]. The gene discussed is MYCN; the disease is neuroblastoma.